| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8258527 | Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease | 2018 | 8 Pages |
Abstract
We have generated a comprehensive set of COIs which sequentially capture different clinical outcome of the three AILDs explored. These indicators represent a critical tool to implement a value-based approach to patients with these conditions, to monitor, compare and improve quality through benchmarking of clinical performance and to assess the significance of novel drugs and technologies. This article is part of a Special Issue entitled: Cholangiocytes in Health and Diseaseedited by Jesus Banales, Marco Marzioni, Nicholas LaRusso and Peter Jansen.
Keywords
DAAsAASLDUDCAULNPBCEGDSEASLAIHHRQOLEQ-5DBMDRASPSCCCAVASIPRprimary biliary cholangitisAmerican Association for the Study of Liver DiseasesEuropean Association for the Study of the LiverUrsodeoxycholic acidesophagogastroduodenoscopyValue-based healthcareautoimmune liver diseasesBone mineral densitometryUpper limit of normalColorectal cancervisual analogue scaleAutoimmune hepatitisLiver transplantationCRCPrimary sclerosing cholangitisCholangiocarcinomahealth related quality of life
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Ageing
Authors
Marco Carbone, Laura Cristoferi, Paolo Angelo Cortesi, Matteo Rota, Antonio Ciaccio, Stefano Okolicsanyi, Marta Gemma, Luciana Scalone, Giancarlo Cesana, Luca Fabris, Michele Colledan, Stefano Fagiuoli, Gaetano Ideo, Luca Saverio Belli,